Clinical Trial Update: Safety Study of Foretinib (GSK1363089) in Adults With Liver Cancer [Phase 1]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 1 safety study of Foretinib (GSK1363089) in adults with hepatocellular carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Foretinib (foretinib)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Carcinoma, Hepatocellular | Phase 1 | Status: COMPLETED